1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC).
Saved in:
| Title: | 1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC). |
|---|---|
| Authors: | Citarella, F.1 (AUTHOR), Russano, M.2 (AUTHOR), Fiorenti, M.1 (AUTHOR), La Cava, G.1 (AUTHOR), Pizzutilo, E.G.3 (AUTHOR), Martinelli, F.3 (AUTHOR), Pierri, S.3 (AUTHOR), Russo, A.4 (AUTHOR), Muscolino, P.4 (AUTHOR), Sapuppo, E.4 (AUTHOR), Marinello, A.5 (AUTHOR), Aldea, M.5 (AUTHOR), Besse, B.5 (AUTHOR), Filetti, M.6 (AUTHOR), Lombardi, P.7 (AUTHOR), Vitale, A.8 (AUTHOR), Buzzacchino, F.9 (AUTHOR), Cristofani, L.10 (AUTHOR), Lugini, A.10 (AUTHOR), Cortellini, A.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS848-S848. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1393 |
